ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Real-Time In Vivo Cellular-Level Imaging During Puncture.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
In the pursuit of precise disease diagnosis, accurate tissue sampling during biopsy is critical. Current CT/ ultrasound-guided biopsies provide macroscopic localization but lack real-time cellular-resolution visualization during puncture, particularly for deep, narrow lumens or small lesions, thereby increasing false-negative and nondiagnostic sampling risks. It's desired to have a puncture with microscopy imaging. Here, we demonstrate an artificial-intelligence-empowered integrative-light-field microendoscopy (AIM) needle. This photonic-mechanically co-engineered probe overcomes dynamic diffraction limits via a closed-loop adaptive optics system integrated in a 25G biopsy needle, enabling diffraction-limited imaging during in vivo puncture. AIM needle resolved characteristic layered microstructures throughout mouse organs (parenchymal/hollow) and pulmonary tumors via synergistic light-field modulation, leveraging K-means and convolutional neural networks to enable in situ pathology-like analysis and tumor/normal tissue discrimination along puncture paths. AIM needle demonstrates dual clinical potential as a complement to macroscopic guidance: potentially providing histology-like feedback without interrupting procedures while enhancing biopsy targeting accuracy through navigation integration, reducing false-negative rates in narrow lumens and microlesions, thereby improving early detection sensitivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.